Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

V 591

Next Previous
Search
Drug Profile

V 591

Alternative Names: Coronavirus vaccine - Themis Bioscience/University of Pittsburgh/Institut Pasteur; TMV-083; V-591

Latest Information Update: 23 Jul 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Institute Pasteur; Themis Bioscience; University of Pittsburgh
  • Developer Institute Pasteur; Merck Sharp & Dohme; Themis Bioscience; University of Pittsburgh
  • Class Adjuvants; COVID-19 vaccines; Synthetic vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued COVID 2019 infections

Most Recent Events

  • 12 May 2021 Institut Pasteur in collaboration with Themis Bioscience completes the phase I COVID-19-101 trial in COVID-2019 infection (Prevention) in France and Belgium (IM)(NCT04497298)
  • 26 Jan 2021 Discontinued - Phase-I for COVID-2019 infections (Prevention) in Belgium, France (IM) based on findings from the trial
  • 26 Jan 2021 Discontinued - Preclinical for COVID-2019 infections (Prevention) in Austria, USA (unspecified route) based on findings from the trial

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top